Top Markets
Coin of the day
XORTX Therapeutics Inc. XORTX Therapeutics Inc.

XORTX Therapeutics Inc.

XRTX
Hisse Senetlerindeki Sıralama #39280
Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm... Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering and bringing to market treatments for a variety of conditions, including progressive kidney disorders, diabetes, insulin resistance, metabolic syndrome, and infections. The company's pipeline includes XRx-008, a late-stage clinical program addressing autosomal dominant polycystic kidney disease; XRx-101, an agent designed to reduce uric acid levels in COVID-19 patients to prevent acute kidney injury and its associated health issues; and XRx-221, a series of xanthine oxidase inhibitor candidates aimed at treating diabetic nephropathy. Furthermore, XORTX Therapeutics collaborates with the Icahn School of Medicine to research the occurrence of acute kidney injury and elevated uric acid in patients hospitalized with COVID-19.
Hisse Fiyatı
$2.06
Son senkronizasyon: 2026-08-11
Piyasa Değeri
$572.30K
Değişim (1 gün)
0.00%
Değişim (1 yıl)
-90.38%
Ülke
CA
Ticaret XORTX Therapeutics Inc. (XRTX)

Kategori

XORTX Therapeutics Inc. (XRTX) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $2.06 - 2026-08-01

Gün sonu en düşük fiyat: $173.60 - 2015-10-01
XORTX Therapeutics Inc. için hisse fiyatı geçmişi: 2015 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) -27.44%
2025 -48.32%
2024 -50.05%
2023 -69.00%
2022 -58.91%
2021 105.10%
2020 -34.17%
2019 8.63%
2018 152.77%
2017 -20.67%
2016 22.14%
2015 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$517.18 32.51%
US
$857.76 31.47%
NL
$728.31 6.63%
CH
$1.07K -6.40%
KR
$254.43 12.40%
BE